Table 1.
Clinical characteristics of Finnish prostate cancer patients.
| Total PrCa sample size | n = 2738 (%) |
|---|---|
| Age at diagnosis (years) | |
| ≤55, young onset | 106 (3.90) |
| >55 | 2632 (96.1) |
| Diagnostic PSA level, ng/mL | |
| Low, ≤20 | 2099 (76.7) |
| High, >20 | 484 (17.3) |
| Missing data | 155 (5.66) |
| Gleason score | |
| Low, ≤6 | 1320 (48.2) |
| High, ≥8 | 368 (13.4) |
| Gleason 7 | 685 (25.0) |
| Missing data | 365 (13.3) |
| T stage | |
| T0/Tx | 13 (0.48) |
| T1 | 1105 (40.4) |
| T2 | 972 (35.5) |
| T3 | 443 (16.2) |
| T4 | 97 (3.54) |
| Missing data | 108 (3.95) |
| N stage | |
| N0/Nx | 2616 (95.5) |
| N1 | 14 (0.51) |
| Missing data | 108 (3.95) |
| M stage | |
| M0/Mx | 2439 (89.1) |
| M1 | 191 (6.98) |
| Missing data | 108 (3.95) |
| PSA progression | |
| Progressed | 960 (35.1) |
| Missing data | 1778 (65.0) |
| Vital status | |
| Deceased of PrCa | 298 (10.9) |
| Deceased of else | 928 (33.9) |
| Alive | 1512 (55.2) |
| Aggressive PC | |
| Yesa | 1019 (55.9) |
| Nob | 804 (44.1) |
aAggressive prostate cancer is defined as PSA at diagnosis >20 ng/mL or Gleason Score ≥8 or T3/T4 or N1 or M1 or PCM.
bNon-aggressive prostate cancer is defined as PSA at diagnosis ≤20 ng/mL and Gleason Score ≤6 and not T3/T4 and not N1 and not M1 and not PC.